Adina Roskies

Michael Cholbi thinks that the claim that motive internalism (MI), the thesis that moral beliefs or judgments are intrinsically motivating, is the best explanation for why moral beliefs are usually accompanied by moral motivation. He contests arguments that patients with ventromedial (VM) frontal brain damage are counterexamples to MI by denying that they have moral beliefs. I argue that none of the arguments he offers to support this contention are viable. First, I argue that given Cholbi's own commitments, he cannot account for VM patients' behavior without attributing moral beliefs to them. Secondly, I show that his arguments that we should not believe their self-reports are unconvincing. In particular, his argument that they cannot self-attribute moral beliefs because they have a defective theory of mind is flawed, for it relies upon a misreading of both the empirical and theoretical literatures. The avenues remaining to Cholbi to support motive internalism are circular, for they rely upon an internalist premise. I provide an alternative picture consistent with neuroscientific and psychological data from both normals and those with VM damage, in which connections between moral belief and motivation are contingent. The best explanation for all the data is thus one in which MI is false.

What happens at the end of a clinical trial for an investigational neural implant? It may be surprising to learn how difficult it is to answer this question. While new trials are initiated with increasing regularity, relatively little consensus exists on how best to conduct them, and even less on how to ethically end them. The landscape of recent neural implant trials demonstrates wide variability of what happens to research participants after an neural implant trial ends. Some former research participants continue to receive support for their devices (e.g., battery and component replacements, software updates, etc.). Others, when safe, have their neural implants removed through surgical explantation. Still others continue to live with a deactivated neural implant embedded in their body. In the United States, there are no uniform requirements to provide services, of any kind, after an neural implant study ends, and other nations are similarly facing this challenge. The existence of a post-trial gap in an expanding neural implant research ecosystem invites obvious questions: What is owed to neural implant research participants post-trial, and why has providing it been so difficult to accomplish in practice? To take a step forward on this difficult issue, we assembled one group of stakeholders – researchers funded for neuroethics grants by the National Institutes of Health – to explore possible starting points on one topic: ethical guidance for post-trial care of research participants in neural implant trials. Based on shared concerns discussed in the expert workshop the current paper is a call to action. It reports the key areas of convergence from the meeting and highlights important next steps towards developing much needed guidance.

Origins of neuroscience, Stanley Finger. Oxford: Oxford University Press, 1994. ISBN 0–19–506503–4Memory in the cerebral cortex: an empirical approach to neural networks in the human and nonhuman primate, Joaquin M. Fuster. Cambridge, MA: MIT Press, 1995. ISBN 0–262–06171–6Artificial minds, Stan Franklin Cambridge, MA: MIT Press, A Bradford Book, 1995 ISBN 0–262–06178–8Pride and a daily marathon, Jonathan Cole. Cambridge: MIT Press, 1995 ISBN 0–262–53136–4; London: Duckworth, 1991 ISBN: 07157–2385–0Objectivity, simulation and the unity of consciousness: current issues in the philosophy of mind (Proceedings of the British Academy, 83) Christopher Peacocke (Ed.) Oxford: Oxford University Press for The British Academy, 1994 ISBN 0–19–726142–6The creative cognition approach, Steven M. Smith, Thomas B. Ward & Ronald A. Finke, (Eds) Cambridge, MA: MIT Press, 1995 ISBN: 0–262–19354‐XMathematics and mind, Alexander George (Ed.) Oxford: Oxford University Press, 1994 $35.00. ISBN 0–19–507929–9.